RecruitingNCT06432023

Imaging - Clinical Evaluation of Altered Nervous System Drainage

Multi-signal Analysis of the Composition and Movement of Fluid in Various Cerebral Compartments in Healthy Subjects and Subjects With White Matter Pathology


Sponsor

IRCCS Eugenio Medea

Enrollment

100 participants

Start Date

Oct 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The current study aims to evaluate the aspects of perfusion, fluid diffusivity in the interstitium and the T1 and T2 signal of the PVS and WMH. The current study has the following objectives: a) evaluate the perfusion aspects using the gadolinium-based contrast medium of brain tissues in the short term; b) the direction of flow of fluids at very low speed in the white matter using the DTI sequences configured for this purpose; c) T1-mapping of the lesions of interest. The expected results will help us understand two aspects of neurofluid dynamics: a) how the fluid moves within the central nervous system in the first minutes after the injection of the tracer (in our case the gadolinium-based contrast medium) and b) what is the composition of the fluid within the PVS and WMH and how can investigators characterize them more accurately.


Eligibility

Min Age: 2 YearsMax Age: 75 Years

Inclusion Criteria1

  • patients with white matter lesions and/or enlarged perivascular spaces

Exclusion Criteria4

  • have contraindications to the use of contrast medium;
  • are clinically unstable patients and prolonged sedation is inappropriate
  • have tumors
  • contraindications to perform MR.

Interventions

DIAGNOSTIC_TESTMagnetic resonance imaging

Diagnostic and research scanning using magnetic resonance imaging.


Locations(1)

Scientific Institute IRCCS E. Medea

Bosisio Parini, Lecco, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06432023


Related Trials